Clinical Trial Update: Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of GW679769 in spinal cord injury patients with overactive bladder was terminated; the update concerns bladder nerve function and related symptoms…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Spinal Cord Injury

Drugs mentioned

• GW679769

Snippet

Sponsor: GlaxoSmithKline | Conditions: Incontinence, Urinary and Urinary Bladder, Overactive, Overactive Bladder | Phase 2 | Status: TERMINATED